Conserved influenza virus epitopes — Drug Target

All drugs that target Conserved influenza virus epitopes — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Recombinant protein vaccine

Phase 3 pipeline (1)

• M-001 · BiondVax Pharmaceuticals ltd. · Recombinant protein vaccine · Immunology / Infectious Disease
  M-001 is a multivalent recombinant influenza vaccine designed to stimulate broad immune responses against multiple influenza strains.